Zecheng Chen
12Patents
5h-index
24Co-inventors
62Inventor score
Filing activity: May 22, 2009 → Nov 6, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8217036B2 | Triazine compounds as PI3 kinase and mTOR inhibitors | Chemistry; Metallurgy | 7 | Active |
| US8039469B2 | Triazine compounds as PI3 kinase and mTOR inhibitors | Chemistry; Metallurgy | 7 | Active |
| US8748421B2 | Triazine compounds as P13 kinase and MTOR inhibitors | Chemistry; Metallurgy | 6 | Active |
| US8859542B2 | Triazine compounds as PI3 kinase and mTOR inhibitors | Chemistry; Metallurgy | 5 | Active |
| US8575159B2 | Triazine compounds as PI3 kinase and mTOR inhibitors | Chemistry; Metallurgy | 5 | Active |
| US10022381B2 | Triazine compounds as PI3 kinase and mTOR inhibitors | Human Necessities | 2 | Active |
| US10086085B2 | Bifunctional cytotoxic agents | Chemistry; Metallurgy | 2 | Active |
| US8445486B2 | Triazine compounds as PI3 kinase and mTOR inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9174963B2 | Triazine compounds as PI3 kinase and MTOR inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10391182B2 | Bifunctional cytotoxic agents | Chemistry; Metallurgy | 0 | Active |
| US10870706B2 | Bifunctional cytotoxic agents containing the CTI pharmacophore | Chemistry; Metallurgy | 0 | Active |
| US11365263B2 | Bifunctional cytotoxic agents containing the CTI pharmacophore | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.